ICAAC 2013
 
September 9, 2013 — September 13, 2013
 
ICAAC, the premier conference on antimicrobial agents and infectious diseases, showcases the latest-breaking science and lectures from top researchers from around the world. With over 60% of its attendees living outside of the United States, ICAAC provides a rare opportunity to bring together the field’s foremost leaders to discuss the state of infection control and prevention on a global scale.
 
 
 
 
Available Packages
ASM Members
 
$349.00 
Student/Post-Doctoral Member
 
$239.00 
Non Member
 
$399.00 
Student/Post-Doctoral Non-Member
 
$299.00 
 
 
  •  
  •  
 
 
 
1 - 100 of 124
Order By 
Show 
Last Page
Page 
Next Page
207
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
501
 
Upon completion of this Slide Session the participant should be able to:
- Describe the latest significant advances in global health parasitology and travel and tropical medicine
- Discuss the epidemiology of travel related illnesses and identify issues in management and prevention of these syndromes
- Discuss advances in vaccine preventable travel related diseases.
$49.99 
 
 
206
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
Upon the completion of this Slide Session the participant should be able to:
- Identify one new approach to assessing targets for antimicrobial stewardship
- Identify one potential adverse effect of antimicrobial stewardship programs
- Identify possible roles for infectious diseases physicians in improving antimicrobial use.
$49.99 
 
 
205
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
401
 
Upon the completion of this Slide Session the participant should be able to:
- Describe epidemiology of carbapenemase - producing enterobacteriaceae in Belgium
- Describe a decolonization regimen that targets extended spectrum beta-lactamase producers
- Describe relationship between MRSA colonization transmission and infection
- Describe relationship between cefepime MICs treatment and outcome.
$49.99 
 
 
204
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
301
 
Upon the completion of this Slide Session the participant should be able to:
- Define the interplay of HIV with other viral pathogens
- Identify the risk factors associated with progression of co-pathogens in HIV
- Describe the clinical consequences of viral co-infections in the setting of HIV.
$49.99 
 
 
203
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
Animals are reservoir of unlimited number of viral infections. Close interactions with animals and environmental factors could promote new outbreaks. The session will review recent and significant viral outbreaks in the field of emerging viruses. Upon completion of this Symposium Session participants should be able to:
- Describe the main characteristics of recent viral outbreaks
- Discuss preventive measures and public health intervention
- Estimate risk for potentially exposed people recognize clinical features and discuss optimal diagnostic strategies.
$49.99 
 
 
202
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
203
 
The goal of this session is to inform the audience on the use of multidisciplinary systems science approach that leverage the recent technologic advances in omics technology to gain a greater insight into the pathogenesis of infectious diseases. Recent efforts such as the NIH Human Microbiome Project and NIAID program for Systems Biology in Infectious Diseases Research highlight the use of advanced interdisciplinary approaches for the understanding of microbiologic processes in human health and disease. The success of such endeavors requires investigators that work as coordinated teams of clinicians basic scientists technology experts bioinformaticians statisticians mathematical modelers and computational biologists. In this symposium examples of microbial systems science approaches will be presenting informing the audience on the nature of information that can be gained from such programs. Audience members will also be given information that will allow them to understand how and why they could get involved in future microbial systems science initiatives. Upon completion of this Symposium Session the participant should be able to:
- Describe the important gains to be made by applying a systems science approach to understanding infectious diseases
- Recommend strategies for using systems biology to study microbial pathogenesis
- Examine the limitations of systems biology; and- Recognize the unanswered questions in systems science.
$49.99 
 
 
201
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
503
 
This symposium will focus on issues related to the prevention of infection in transplant recipients. Organ specific hospital associated infections will be reviewed. Tailoring surgical prophylaxis to donor and recipient cultures will be discussed. Infection control practices that are specific to transplantation will be evaluated. Vaccination strategies for infection prevention in this population will be considered. Upon completion of this Symposium Session the participant should be able to:
- Identify the impact of infection control practices on health care associated infections in transplant recipients
- Discuss how vaccination and surgical prophylaxis may prevent infections in transplant recipients
- Review transplant organ specific considerations related to hospital associated infections.
$49.99 
 
 
200
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
113
 
This symposium will summarize state-of-the-art progress in development of a universal influenza vaccine vaccines for prevention of CMV Dengue and Streptococcus B infections. Each of these vaccines would impact health dramatically and on a global scale. Upon completion of this Symposium Session the participant should be able to:
- Discuss progress toward and challenges remaining to development of a vaccine to prevent Dengue
- Discuss progress toward and challenges remaining to develop a prophylactic Streptococcus B vaccine
- Discuss progress toward and challenges remaining to realization of a universal vaccine for influenza
- Discuss progress toward and challenges remaining to realization of a universal vaccine for CMV.
$49.99 
 
 
199
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
This session will review the epidemiology diagnosis and prevention of pertussis. The factors contributing to the recent surge in the incidence of pertussis will be highlighted. New diagnostic platforms and the best approaches to the diagnosis of this disease will be discussed. Data on the efficacy of the current acellular pertussis vaccines and novel strategies for control and prevention will also be presented. Upon completion of this Symposium Session the participant should be able to:
- Discuss factors that may be contributing to the current surge of pertussis infections worldwide
- Identify the best approaches to the laboratory diagnosis of pertussis
- Asses the issues relating to decreased efficacy of current vaccines
- Discuss potential strategies for prevention and control of pertussis.
$49.99 
 
 
198
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
112
 
Antibiotic resistance continues to increase and spread globally. With the advent of carbapenemases such as KPC-2 and NDM-1 colistin and polymyxin have become drugs of last resort to treat multi-drug resistant Gram-negative bacteria. However in recent years reports of resistance to these drugs have emerged. The epidemiology and molecular mechanisms of resistance to colistin and polymyxin will be explored. Upon completion of this Symposium Session the participant should be able to:
- Discuss the world wide prevalence of resistance to colistin and polymyxin
- Identify the species in which resistance to these agents may occur
- Examine the molecular mechanisms responsible for resistance.
$49.99 
 
 
197
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
505
 
Infection due to C. difficile remains a major clinical challenge especially with the emergence of recent epidemic strains. This session will examine both basic science and clinical aspects of this pathogen that are important for disease. It will address the role of host-pathogen interactions in the establishment and persistence of infection and the changing epidemiology of this disease. It will also look at new strategies to prevent transmission and the role of antibiotic stewardship to prevent infection. Upon completion of this Symposium Session the participant should be able to:
- Define the key features of C. difficile that lead to invasive disease and persistence of infection
- Summarize how the epidemiology of C. difficile disease has changed
- Formulate what strategies can be used to limit transmission
- Recommend practices that can be implemented to optimize antimicrobial use such that C. difficile infection is less likely to develop.
$49.99 
 
 
196
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 1
 
State-of-the-art management of aspergillosis mucormycosis black molds and cryptococcosis will be discussed. Recent research questions addressed comprise e.g. antifungal combination treatment the ideal timing and extent of multimodal approaches including surgery. Upon completion of this Interactive Symposium Session the participant should be able to:
- Apply effective antifungal treatment strategies
- Review latest research results
- Discuss treatment changes based on recent clinical trials results.
$49.99 
 
 
195
Date:
Friday, Sep. 13, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 4
 
Antimicrobial resistance is an urgent public health problem. New ways to prevent the emergence of drug resistance and treat it when present are required. This symposium will address the use of combination antimicrobial chemotherapy for the prevention and management of drug resistance for a range of microbial pathogens. Upon completion of this Interactive Symposium Session the participant should be able to:
- Discuss the role of PK/PD in setting in vitro susceptibility breakpoints
- Examine the limitations of PK/PD for setting in vitro susceptibility breakpoints
- Identify the future role and regulatory requirements of using PK/PD for setting breakpoints.
$49.99 
 
 
194
Date:
Friday, Sep. 13, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
This meet-the-experts session will focus on new developments in fungal infections in hematopoetic and solid organ transplant recipients. Optimal evidenced-based prophylactic strategies for prevention of fungal infections in solid organ transplant recipients will be reviewed. The role of combination therapy for fungal infections will be discussed.Upon completion of this Meet-the-Experts Session the participant should be able to:
- Review the strategies for prevention of fungal infections in solid organ transplant recipients
- Recognize the potential benefits and risks of different antifungal agents for treatment of infection in stem cell transplant recipients
- Discuss the evidence behind different. strategies of treatment and prevention in high risk transplant recipients
$49.99 
 
 
193
Date:
Friday, Sep. 13, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
The session outlined is designed to provide a high-quality evidence-based educational opportunity to advance the competence of attending physicians trainees and professionals. In this Meet-the-Experts session key issues in migrant health will be discussed. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Cite recent examples of advances in travel and tropical medicine which can be incorporated into addressing issues they face in the area of migrant health.
$49.99 
 
 
192
Date:
Friday, Sep. 13, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
113
 
Guidelines for emerging fungal infections are lacking although the clinical need for guidance is particularly high in less frequent diseases where the individual physician may not be able to develop routine approaches. The guidelines presented and discussed will enable the participant to gain in depth knowledge in the areas of rare and emerging hyalohyphomycosis as well as invasive yeast infections other than candida. Upon completion of Meet-the-Experts Session the participant should be able to:
- Identify the most relevant emerging organisms causing invasive fungal infections
- Perform complete diagnostic work ups in rare and emerging fungal infections
- Measure treatment success and recognize treatment failure early.
$49.99 
 
 
190
Date:
Friday, Sep. 13, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
This session will discuss the epidemiology of healthcare-associated infection in pediatric patients and preventive strategies to be implemented in this setting. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the epidemiology of healthcare-associated infections in neonatal and pediatric patients;
- Describe effective strategies for the prevention and control of infection in pediatric care settings
- Identify the best evidence-based strategies to apply in the pediatric setting.
$49.99 
 
 
189
Date:
Friday, Sep. 13, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
205
 
Use of antiretroviral therapy for pre-exposure prophylaxis is a new tool for HIV prevention that could help containing the HIV/AIDS epidemic worldwide. Following the results of recent clinical trials FDA has recently approved the use of antiretroviral therapy for PrEP in high risk individuals. The implementation of PrEP faces a number of challenges and new drugs and new delivery systems are being assessed. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Review current data on the use of antiretroviral agents for HIV prevention
- Discuss the challenges of using antiretrovirals for prevention and estimate the likelihood of success of this strategy in developed and developing world settings
- Discuss the pharmacokinetics of new antiretroviral agents used for prevention and assess their potential efficacy
- Discuss the new drug delivery systems for PrEP.
$49.99 
 
 
188
Date:
Friday, Sep. 13, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
501
 
Those attending this session will be apprised of advances and promising developments in the prevention of HIV and other STDs in adolescents and young adults. There will be ample opportunity for attendees to add comments pose questions and interact with the experts. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the epidemiology of HIV and other STD in adolescents - Propose counseling to adolescents on prevention of HIV and STD
- Produce an overall approach on the management of young people with HIV and other STDs.
$49.99 
 
 
187
Date:
Friday, Sep. 13, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
301
 
This meet-the-experts session will provide an update on the latest developments in surveillance and molecular epidemiology of antimicrobial resistant organisms (AROs) such as MRSA VRE S. pneumoniae and multidrug-resistant gram-negatives. The experts will describe interesting publications in the field of surveillance and molecular epidemiology of AROs from 2012 and 2013. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Recognize the changing molecular epidemiology of AROs
- Discuss the latest surveillance data published in 2012-13 of AROs
- Recognize interesting publications in the field of surveillance and molecular epidemiology of AROs from 2012 and 2013.
$49.99 
 
 
186
Date:
Friday, Sep. 13, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
401
 
Guidelines for therapeutic monitoring of vancomycin in adult patients are currently being updated. This meet-the-experts session will update participants about recent considerations concerning monitoring serum vancomycin concentrations and dosage recommendations. The pharmacokinetic/pharmacodynamic rationale and published reports to support new therapeutic drug monitoring guidelines will be reviewed. Issues regarding tissue penetration nephrotoxicity and dosage recommendations of vancomycin in specific patient populations will be appraised. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Describe the current therapeutic drug monitoring guidelines for vancomycin therapy
- List the key pharmacokinetic/pharmacodynamic considerations for dosing vancomycin
- Appraise the use of serum vancomycin concentrations in various patient populations and clinical infections.
$49.99 
 
 
185
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
113
 
Upon the completion of this Slide Session the participant should be able to:
- Describe the epidemiology of respiratory viruses in adults and children
- Evaluate new treatment modulates for critically ill patients with influenza
- Understand mechanisms of resistance to neuraminidex inhibitors.
$49.99 
 
 
184
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
505
 
Upon the completion of this Slide Session the participant should be able to:
- Interpret efficacy and safety of combination art with integrate inhibitors
- Identify important PK interactions in antiretroviral therapy
- Demonstrate management of HIV therapy in pregnancy.
$49.99 
 
 
183
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
503
 
Upon the completion of this Slide Session the participant should be able to:
- Examine new technologies for anthrax RSV and CMV vaccines
- Identify the impact of pneumococcal vaccines (PCV7 PCV 13) and Meningococcal C vaccines
- Identify the epidemiology of pertussis and mumps in the Post-vaccine era.
$49.99 
 
 
182
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
Upon the completion of this Slide Session the participant should be able to:
- Apply an over view of molecular epidemiology of carbapenemases
- Distinguish new data about the complexity in the epidemiology of microorganisms harboring these enzymes
- Formulate information that would be useful to design infection control activities.
$49.99 
 
 
181
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
405
 
Upon the completion of this Slide Session the participant should be able to:
- Locate the role of efflux in bacterial resistance
- Examine the interplay of outer membrane proteins in bacterial cell penetration
- Discover the range of antibiotics affected by efflux.
$49.99 
 
 
180
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
Upon the completion of this Slide Session the participant should be able to:
- Describe the effects of drugs on immune response to infection
- Examine the effects of immune factors on pathogenetics of infection
- Describe role of host genetic factors on pathogenetics of infection.
$49.99 
 
 
179
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
205
 
This symposium will review key infections that may affect outcomes after solid organ and hematopoetic stem cell transplant including Burkholderia cepacia Aspergillus Hepatitis C and Tuberculosis. Contraindications to transplantation will be outlined. Prophylactic interventions will be discussed and post-transplant management strategies reviewed. After this symposium the attendee will have a better understanding of how to manage patients with these infections which have often been considered to be relative or absolute contraindications to transplantation. Upon completion of this Symposium Session the participant should be able to:
- Recognize infections that may present unique challenges to transplantation
- Discuss when pre transplant infections are absolute contraindications to transplantation
- Evaluate prophylactic measures for transplant candidates with difficult to treat infections.
$49.99 
 
 
178
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
401
 
Recent award recipients from the developing and developed world will describe their winning proposals and their potential impact. Upon completion of this Symposium Session the participant should be able to:
- Cite the award winning proposals and the paths taken to successfully develop a funded academic career in global health research
- Discuss the Rising Stars program and the role of new funding opportunities for trainees in infectious diseases and global health.
$49.99 
 
 
177
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
301
 
This is a critical analysis of what the faculty of this symposium considers the most interesting and exciting published papers in mycology over the year. These papers can range from basic to the clinical arena with a primary emphasis on the discussion of fungal diseases and their epidemiology diagnosis and treatment. It is hoped that authors of manuscripts will be in the audience to provide a lively discussion. Upon completion of this Symposium Session the participant should be able to:
- Discuss principles in fungal pathogenesis diagnosis treatment and epidemiology
- Identify the strengths and weaknesses of specific fungal related manuscripts
- Focus on the important issues of clinical mycology today.
$49.99 
 
 
176
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
112
 
Infections that complicate pregnancy and delivery are important causes of maternal and child morbidity and mortality. This session focuses on major infectious disease threats in pregnant and postpartum women. Attendees of this symposium will gain new knowledge about chorioamnionitis malaria during pregnancy puerperal sepsis and infections that complicate unsafe abortion. Upon completion of this Symposium Session the participant should be able to:
- Discuss the important consequences of chorioamnionitis
- Recommend strategies for recognizing infectious diseases that complicate pregnancy
- Examine the features and consequences of malaria during pregnancy
- Recognize the infections that complicate unsafe abortion.
$49.99 
 
 
175
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
501
 
Upon completion of this Symposium Session the participant should be able to:
- Discuss the cardinal and distinguishing clinical symptoms and signs of infections presenting in developing countries
- Examine empirical management of fever meningitis or encephalitis
- Identify the role of combination therapy in cysticercosis and echinococcosis.
$49.99 
 
 
174
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
203
 
There are still many unanswered questions in regard to the details of bacterial death particularly upon exposure to certain antibiotics. This is particularly true of the fluoroquinolone class. Also not all members of a bacterial population are necessarily killed as so-called persisters can survive and prolong infections. A better understanding of these processes could assist in the identification of new classes of antibacterial drugs. Upon completion of this Symposium Session the participant should be able to:
- Distinguish bacterial cell death upon antibiotic exposure
- Differentiate molecular biochemical and cellular events that occur as bacteria are killed
- Examine bacterial persisters and their role in bacterial infections.
$49.99 
 
 
173
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
Alternative strategies for administering anti-infective agents are increasingly being used to improve anti-infective pharmacotherapy. In addition alternative dosing and administration strategies of several new anti-infective agents are actively being pursued in drug development programs. This symposium is aimed at providing clinicians and researchers with the latest developments on alternative techniques for administering anti-infective agents discuss the pharmacokinetic/pharmacodynamic considerations of these dosing strategies and illustrate current applications for the treatment of clinical infection diseases. Upon completion of this Symposium Session the participant should be able to:
- Evaluate the role of intraventricular administration of vancomycin for central nervous system infections
- Describe the pharmacokinetic/pharmacodynamic issues associated with aerosol delivery of antibiotics
- Appraise the use of extended infusions of beta-lactam agents in various patient populations
- Propose an individualized dosing method for anti-infective agents with a narrow therapeutic index.
$49.99 
 
 
172
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 4
 
This session will address several controversial topics in infection prevention. The question of whether hand hygiene is the most important infection prevention activity will be addressed through a debate. The question of whether antimicrobial coatings on surfaces or fabrics are an important infection prevention measure will be addressed through a literature review. The question of whether no touch disinfection methods (e.g. UV light hydrogen peroxide vapor) are important infection prevention measures will be addressed through a literature review. Upon completion of this Interactive Symposium Session the participant should be able to:
- Discuss the evidence for and against hand hygiene being the most important infection prevention measure
- Discuss the evidence for and against antimicrobial coatings as an infection prevention measure
- Discuss the evidence for and against no touch disinfection methods (e.g. UV light hydrogen peroxide vapor) as an infection prevention measure.
$49.99 
 
 
171
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 1
 
The conveners will present a selection of challenging cases in pediatric infectious diseases. Conveners will solicit discussion from panelists as to differential diagnosis and approach to evaluation and management. Questions will be posed in the audience response format so that attendees can weigh-in as a measure of their personal diagnostic and therapeutic acumen. Conveners will prepare a brief summary of the important teaching points for each case presented. Upon completion of this Interactive Symposium Session the participant should be able to:
- Identify some common and not-so-common clinical manifestations of important infectious diseases in childhood
- Identify medical evidence and current expert opinion in management and prevention of infections in childhood
- Assess and compare knowledge anonymously with peers
- Recognize and identify unusual infectious diseases.
$49.99 
 
 
170
Speaker:
 
Date:
Thursday, Sep. 12, 2013
 
Time:
1:30 pm –  2:30 pm
 
Track:
Special Address
 
Recording Type:
Live Stream
 
Room:
Mile High Ballroom 3
 
Dr. Trevor Mundel, renowned scientist and President of Global Health-Program at the Gates Foundation, will discuss the vision for global health and infectious diseases from the foundation's perspective. Dr. Mundel will address current vaccine discovery programs, strategies for the future, neglected diseases and plans for accelerating research and development efforts for low resource settings through new partnerships and programs.

$49.99 
 
 
140
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
Upon the completion of this Slide Session the participant should be able to:
- Assess study the epidemiology of severe infection in neutropenic and hemato-oncology patients
- Assess prevention and control measures for the prevention of bloodstream infection among neutropenic patients
- Determine infection control in high-risk patients.
$49.99 
 
 
139
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
Upon the completion of this Slide Session the participant should be able to:
- List 3 risk factors for surgical site infections
- Describe one novel approach to diagnosis of prosthetic joint infections
- List one novel approach to prevention of surgical site infections
- Describe one novel option for treatment of prosthetic joint infections
$49.99 
 
 
138
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
501
 
Upon the completion of this Slide Session the participant should be able to:
- Assemble gut microbiota in ELBW infants
- Idenitfy vancomycin pharmacokinetics and resistance
- Discuss epidemiology of meningococcal carriage and infection
- Examine epidemiology of group A streptococus colonization and pharyngitis
- Identify diagnostic conflicts in VAP.
$49.99 
 
 
137
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Recording Type:
Live Stream
 
Room:
Mile High Ballroom 3
 
Chronic hepatitis C is a complex disease for which new treatments are available but potentially associated with serious adverse events. The goal is to review and carefully assess the role of new therapeutic options. Upon completion of this Symposium Session the participant should be able to:
- Describe the role of new anti-HCV drugs
- Identify treatment strategy risk side effects and benefits
- Discuss the role of laboratory tools used to monitor HCV
- Identify how to prevent HCV complications in HIV infected patients.
$49.99 
 
 
136
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
401
 
This symposium will focus on new developments in the diagnosis and management of herpesvirus infections. Specifically the impact of the new international standard for CMV and the interpretation of low viral loads will be discussed. The results of the 2012 CMV consensus conference will be reviewed. New therapeutics including immune based therapies and novel antivirals will be presented. Upon completion of this Symposium Session the participant should be able to:
- Discuss the impact of the new international standards on CMV diagnosis
- Recognize different options for prevention and treatment of CMV based on international consensus guidelines
- Evaluate treatment options for herpes viruses.
$49.99 
 
 
135
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
This session provides an overview of the problem of multidrug-resistant gram-negative bacterial infections including proposals for future key studies surveillance issues and the associated economic burden. Infections due to MDR gram-negative bacteria such as ESBL or carbapenemase-producing Enterobacteriaceae and A. baumannii or P. aeruginosa are a serious problem in the hospital setting. Most health professionals are seeing rising numbers of these and face increasingly difficult challenges to define appropriate treatment and prevent transmission.Upon completion of this Symposium Session the participant should be able to:
- Examine the profile of resistance to currently used antimicrobial agents
- Identify current controversies in antimicrobial resistance
- Analyze an overview on the global epidemiology of multidrug-resistant gram-negatives and associated costs
- Describe how future academic research could progress to gain greater insight into transmission control strategies.
$49.99 
 
 
134
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
203
 
Antiretroviral therapy continues to evolve with several new combination first line therapies now available allowing for further individualization of therapy. Multiple potential treatment regimens for first line failures are possible but data are limited and choices in resource rich and resource limited setting may be different. Expert insight into decision making is critical. Finally an update on the pipeline on new antiretroviral will be provided. Are the new options for the future or has the flow in the pipeline become a trickle? Upon completion of this Symposium Session the participant should be able to:
- Discuss choices for initial antiretroviral therapy of HIV-1 infection and understand the advantages and disadvantages of preferred regimens
- Discuss options for second line therapy in patients who have virologic failure on first line therapy. Understand how these options may differ depending on treatment setting
- Review new drugs in the HIV-1 treatment pipeline and how they may be used when they become available.
$49.99 
 
 
133
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
205
 
The outer membrane of gram-negative bacteria presents a formidable barrier to the free access of the majority antibiotics to their cellular targets. Bacteria maintain transport systems in the outer membrane that constitute the principal route by which antibiotics enter the cell and efflux systems that serve to limit entry by actively pumping the compounds out again. Resistance can be achieved through decreasing the activity of the uptake path or through increasing the efflux path. The session will review recent highlights in the understanding of how these transport and efflux systems contribute to the activity of antibiotics. Upon completion of this Symposium Session the participant should be able to:
- Discuss the translocation of antibiotics across the gram-negative bacteria
- Identify the role of transport systems in bacterial resistance
- Examine the development of new drugs that can better exploit translocation routes.
$49.99 
 
 
132
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
405
 
Matrix assisted laser desorption ionization time of flight (MALDI-ToF) mass spectrometry (MS) is increasingly used in clinical microbiology laboratories for bacterial and fungal identification. Newer applications such as strain typing and antimicrobial susceptibility testing are evolving. This session delivered by experienced users of the technology will be a state-of-the-art presentation on this technology and its clinical application(s). Upon completion of this Symposium Session the participant should be able to:
- Review MALDI-ToF MS for bacterial and fungal identification
- Assess what clinicians should know about MALDI-ToF MS and how it is utilized in clinical microbiology
- Review unsettled issues and pitfalls of current MALDI-ToF MS methods and their clinical application.
$49.99 
 
 
131
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
301
 
This session will provide an overview on the latest developments in clinical aspects of carbapenemase-producing bacteria. The session will start with an introduction to the different carbapenemases (i.e. VIMs IMPs NDMs KPCs OXAs). This will be followed by lectures summarizing the latest data on the molecular epidemiology laboratory detection and treatment issues of bacteria that produce these types of carbapenemases. The session is important for all physicians and laboratory personal that are involved in health care aspects of patients infected with bacteria that produce carbapenemases. Upon completion of this Symposium Session the participant should be able to:
- Discuss the clinical importance of bacteria that produce carbapenemases
- Recognize the changing epidemiology of bacteria that produce carbapenemases
- Identify how to approach the laboratory detection and screening of bacteria that produce carbapenemases
- Recommend which treatment options are available for infections due to bacteria that produce carbapenemases.
$49.99 
 
 
130
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
113
 
The cell wall is one of the most unique features of bacterial pathogens. From the discovery of penicillin the machinery involved in cell wall synthesis has been exploited for antimicrobial therapy. This symposium on the bacterial cell wall will provide an overview of this important antibacterial drug target. The genes and the machinery involved in constructing the cell wall and cell division will be explored. Upon completion of this Symposium Session the participant should be able to:
- Identify the basic component of the bacterial cell wall
- Discuss the function genes involved in cell wall assembly and cell division
- Identify potential drug targets in this pathway.
$49.99 
 
 
128
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
503
 
Community-acquired invasive infections due to S. aureus have increased significantly in recent years. This session will examine the underlying mechanisms for the emergence of highly invasive disease including persistent bacteremia. It will also address possible human genetic factors that affect the course of infection. Finally we will examine the prospects for developing a vaccine against S. aureus. Upon completion of this Symposium Session the participant should be able to:
- Distinguish the role of virulence factors such as toxins in the pathogenesis of invasive S. aureus infection
- Differentiate the key clinical features of sustained bacteremia due to USA300 and related isolated from infection due to other strains
- Discuss some novel strategies for vaccine development and what sets them apart from prior unsuccessful approaches
- Explain how genetic differences may lead to enhanced susceptibility to S. aureus disease.
$49.99 
 
 
127
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 4
 
Pneumonia is a major cause of morbidity and mortality. This session provides an update on causative pathogens associated with community-acquired pneumonia. It also reviews the latest information regarding pneumonia in special populations such as older adults and people living in resource-poor settings. The prevention of pneumonia through vaccination of adults and other measures will also be updated. International experts in the field will deliver these talks to ensure the most important and cutting edge information is provided. Upon completion of this Interactive Symposium Session the participant should be able to:
- Discuss the important microbial pathogens implicated in community-acquired pneumonia (CAP)
- Recommend strategies in adults to prevent CAP
- Examine the causes of CAP in resource poor settings and older adults
- Recognize the impact of molecular techniques in understanding the causes of pneumonia.
$49.99 
 
 
126
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 1
 
Antimicrobial resistance is an urgent public health problem. New ways to prevent the emergence of drug resistance and treat it when present are required. This symposium will address the use of combination antimicrobial chemotherapy for the prevention and management of drug resistance for a range of microbial pathogens. Upon completion of this Interactive Symposium Session the participant should be able to:
- Identify the use of combination chemotherapy for the prevention and treatment of antimicrobial resistance
- Recognize the pros and cons of using combinations of antimicrobial agents as a strategy for combating resistance
- Discuss the limitations of current knowledge and areas for future research.
$49.99 
 
 
124
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
205
 
This meet-the-expert session will focus on infection control issues that are relevant to transplant recipients. The impact of antimicrobial stewardship on hospital-acquired infections including with multi drug resistant pathogens will be discussed. Infection control issues pertaining to respiratory virus infections a significant cause of hospital acquired infections on transplant units will also be reviewed. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Recognize the impact of antimicrobial selection on hospital acquired infections in transplant recipients
- Discuss how infection control measures may affect the spread of respiratory viruses on transplant units
- Review important infection control issues related to transplant recipients.
$49.99 
 
 
123
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
401
 
After brief introductory state-of-the-art lectures on two primary reasons for treatment failure i.g. fungal resistance and host genetic susceptibility the experts and the audience will engage in a discussion on how to deal with these two and other obstacles in managing invasive fungal infection. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Debate reasons for failure of antifungal treatment
- Classify antifungal drugs by their potential to fail
- Integrate fungal resistance and host genetics into clinical decision making processes.
$49.99 
 
 
122
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
405
 
In this discussion the experts will use both their experience with cryptococcosis in AIDS patients and those with non-AIDS cryptococcosis. There will be discussion of diagnosis pathogenesis and treatment of this deadly and common disease. Furthermore these experts will be able to discuss both cryptococcal species (C. gattii and C. neoformans) and their impact on the immune system.Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the Immune Reconstitution Inflammatory Syndrome
- Discuss issues around management of cryptococosis
- Provide the framework for understanding C. neoformans and C. gattii infections.
$49.99 
 
 
121
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
505
 
Sexually transmitted infections (STIs) are a major threat to reproductive health. The field is challenged by the emergence of drug-resistant pathogens and the presence of HIV in association with other STIs. In addition the diagnostic approach to STIs is changing as more molecular and rapid tests are coming into clinical practice. This session will provide an interactive forum for attendees to ask leading experts about the diagnosis management and epidemiology of STIs. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the important STIs affecting patients around the world
- Recommend strategies for diagnosing STIs
- Examine the evidence base for our current approaches to STI management
- Recognize the latest developments in STI epidemiology diagnosis and treatment.
$49.99 
 
 
120
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
112
 
The session will bring together an ENT surgeon with an infection/microbiology specialist to talk through how they manage some of the clinical scenarios that infection specialists find most challenging including for example chronic rhinosinusitis (bacterial/fungal) and malignant otitis. While there are guidelines published for common ENT conditions such as acute sinusitis there are no guidelines for the more infrequent but lethal conditions. The session aims to provide some practical solutions for difficult clinical cases. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Evaluate and apply accepted management guidelines for serious ENT infections
- Determine the most practical and effective management plans for rhinosinusitis
- Examine the patients who will require combined medical and surgical therapy.
$49.99 
 
 
119
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
The speakers will identify and discuss important infection and prevention publications from the past year. This review will give attendees an overview of the most significant findings in this field and will put the findings in perspective. Attendees are likely to learn about papers that they have not encountered on their own and will be challenged to evaluate practices at their healthcare facilities. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Identify several of the most significant publications in infection prevention in the past year
- Discuss the important findings of at least one of these publications
- Identify at least one infection prevention and control issue that their healthcare facility should address in the next year.
$49.99 
 
 
118
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
203
 
The optimal use of antiretroviral therapy for the prevention of mother to child transmission has dramatically changed the risk of HIV-1 transmission to infants in the developed and developing world. In the developed world transmission from mother to child should be uncommon but there are still infants at risk due to late presentation to care HIV-1 resistance to antiretrovirals and adherence/tolerability of medications. In the developing world recent studies have shown that maternal treatment with combination therapy may be the most effective intervention but implementation may be challenging. Two world experts will provide their guidance on these issues. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Review current practice guidelines on the use of antiretroviral agents for prevention of mother to child transmission in the developed world
- Review recent data on prevention of mother to child transmission in the developing world
- Discuss potential clinical and logistical issues that prevent optimal use of antiretroviral therapy for PMTCT
- Examine the logistical hurdles of reaching the goals of zero MTCT in the next decade.
$49.99 
 
 
117
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
301
 
Increased incidence of antibiotic resistance has eroded the effectiveness of these valuable drugs. Combined with the decline of R&D in the large pharmaceutical companies over the past 10-15 years few new antibiotics have reached the market in recent times. Regulatory guidelines particularly in the US have also contributed to reduced development candidates. This session will discuss these issues and explore potential solutions to improve the antibiotic pipeline. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the problems confronting antibiotic development today
- Identify initiatives to facilitate antibiotic development
- Examine insights into the development of new drugs for today's needs.
$49.99 
 
 
116
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
β-lactamases are the major cause of resistance to β-lactam antibiotics. Since the discovery of penicillin bacteria have evolved to produce β-lactamases capable of inactivating each new class of β-lactam antibiotics. Every year there are a plethora of publications regarding β-lactamases and cover a variety of subjects including epidemiology genetic and biochemical characterizations structural elucidation and clinical impact. Ten interesting and impactful publications from the literature in 2013 will be chosen and discussed by the team of experts. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Identify current literature in β-lactamases
- Discuss novel findings in current publications
- Examine the impact of new research.
$49.99 
 
 
115
Date:
Wednesday, Sep. 11, 2013
 
Time:
5:45 pm –  7:15 pm
 
Track:
Special Interest Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
$49.99 
 
 
114
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
207
 
Upon the completion of this Slide Session the participant should be able to:
- Recognize patters of infection in hematopoietic stem cell recipient
- Discuss the impact of bacterial infections on outcomes in transplantation
- Analyze geographically restricted infection patterns in transplantation.
$49.99 
 
 
113
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
Upon the completion of this Slide Session the participant should be able to:
- Describe mechanisms on decreasing resistance in developing world
- Describe the prevalence on antimicrobial resistance in developing world
- Describe mechanisms of resistance in returning travelers.
$49.99 
 
 
112
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
301
 
Upon the completion of this Slide Session the participant should be able to:
- Apply data on the occurrence and dissemination of clinically significant anti-microbial marker among gram-positive cocci
- Report updated information on the evolution of antimicrobial resistance and molecular characterization among staphylococci
- Examine data on the impact of pneumococcal vaccines on the emergence of non-vaccine S. pneumonia serotypes and on the evolutions of antimicrobial resistance.
$49.99 
 
 
111
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
112
 
Infectious disease physicians and microbiologists frequently manage infections in patients with underlying disorders that do not fall into classical transplant immunosuppression or acquired immunodeficiency categories. This session will provide fresh insight into single gene disorders that predispose to infection and enable infection specialist to identify and manage such patients more effectively. The pathophysiology of such disorders and the consequent infections will be of interest to both clinical and non-clinical attendees. Many patients within haematological practice are hyposplenic either through splenectomy or functional hyposplenism; ID physicians and microbiologists should be aware of the specific immune defects that may arise and guidance that is available regarding monitoring of such patients and prophylaxis. Upon completion of this Symposium Session the participant should be able to:
- Examine and recognize infection linked to single gene defects in transcription factors
- Describe infections linked to genetic defects in haemoglobin
- Review the immunological defects and infection risks linked to splenectomy and practice recommendations.
$49.99 
 
 
110
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
501
 
The disruption of the human microbiome through use of antimicrobials is a topic of growing interest among healthcare epidemiologists not only because perturbation of the microbiome is the major risk factor for Clostridium difficile infection (CDI) but also because it could be a driving force behind the introduction and proliferation of multidrug-resistant organsms (MDROs) in healthcare settings. A greater understanding of the protective role of the microbiome could have major implications for the future direction of infection control. The speakers will review the current understanding of the role of microbiome disruption in the epidemiology of diseases such as CDI and MDRO colonization and transmission and what the future may hold with regard to intervention. Upon completion of this Symposium Session the participant should be able to:
- Discuss the relationship between antimicrobial use and disruption of the human microbiome
- Review the rationale for and data supporting use of fecal transplantation in treatment and prevention of Clostridium difficile infection
- Discuss the potential role of probiotics in preserving or restoring a disrupted microbiome
- Discuss CDI in pediatric populations.
$49.99 
 
 
109
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
505
 
In this session experts will present state-of-the-art advances in pediatric infectious diseases in lecture format. Time will be available after each presentation for questions from attendees and additional discussion. Upon completion of this Symposium Session the participant should be able to:
- Discuss contemporary advances in pathogenesis diagnosis and treatment of key pediatric infectious diseases and their importance to child health
- Summarize the potential impact of implementation of scientific advances to improve child health
- Apply updated information to communication decision-making and clinical practice.
$49.99 
 
 
108
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
405
 
β-lactamase-mediated resistance to β-lactams such as cephalosporins and carbapenems is increasing among the gram-negative bacteria and is of growing concern. The combination of β-lactamase-labile penicillins (for example amoxillin or piperacillin) with a specific β-lactamase inhibitor has proven to be an effective strategy for contering this threat. The session will review new β-lactamase inhibitors hold the promise to encompass the emerging carbapenemases that pose a severe threat the carbapenems and thus restore the activity of these agents against gram-negative bacteria. Upon completion of this Symposium Session the participant should be able to:
- Discuss the problems associated with β-lactamase-mediated resistance
- Examine mechanism-based inhibitors of β-lactamases
- Discuss insights into the development of new combinations of β-lactams and β-lactamase inhibitors.
$49.99 
 
 
107
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
503
 
Bacterial biofilms are a major clinical challenge and inherently resistant to antimicrobials this session will examine a number of novel approaches to treat or prevent biofilm infections. Speakers will present data regarding new methods to study biofilms as well as strategies to destroy and inhibit biofilm formation. Upon completion of this Symposium Session the participant should be able to:
- Discuss the role of biofilms in infection
- Discuss the structure and formation of biofilms
- Analyze novel approaches being developed to inhibit or destroy biofilms
- Discuss different methods used for the study of biofilms
$49.99 
 
 
106
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
113
 
In this session up-to-date CLSI and EUCAST recommendations and guidelines regarding antimicrobial susceptibility testing will be presented. There will also be special focus on antimicrobial susceptibility testing of hepatitis C virus and Candida species. Challenges controversies and the current state-of-the-art will be addressed. Upon completion of this Symposium Session the participant should be able to:
- Review current CLSI and EUCAST guidelines regarding antimicrobial susceptibility testing
- Assess what clinicians should know about and when to request antimicrobial susceptibility testing for clinical care
- Review unsettled issues and pitfalls of current antimicrobial susceptibility testing methods and their clinical application.
$49.99 
 
 
105
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
203
 
This session will provide an overview on present areas of interest in sepsis. It will include two topics about cutting-edge research areas on pathogenic aspects (such as implications of endothelial activation and dysfunction and dendritic and myeloid-derived suppressor cells). Also 2 areas of immediate interest for clinical application will be covered: novel tools for rapid diagnostics of sepsis which is a critical aspect for the outcome of patients and combination therapy a highly controversial topic that will be addressed from the perspective of evidence-based medicine. Upon completion of this Symposium Session the participant should be able to:
- Discuss the role of endothelial activation and dysfunction and dendritic and myeloid-derived suppressor cells in the pathogenesis of sepsis and their implications for potential innovative therapeutic approaches
- Recommend the best novel tools for early diagnosis of sepsis and know their limitations and advantages
- Identify whether combined antimicrobial therapy is to be used in patients with sepsis or under which circumstances.
$49.99 
 
 
104
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
205
 
That session aims to provide an overview about the mechanisms leading to carbapenem resistance in Gram negatives. The major resistance determinants threatening a large part of the world namely KPC and OXA-48 will be presented in detail. Genetic but also epidemiological aspects will be widely covered. In addition those mostly found in Pseudomonas aeruginosa will be presented and the audience will be able to appreciate to which extent they differ from the former ones. Finally the recent and detailed genetic characterizations of plasmids bearing carbapenemase genes (encoding OXA-48, KPC, NDM...) will be presented. Upon completion of this Symposium Session the participant should be able to:
- Identify molecular mechanisms behind the success of the emerging carbapenemases
- Examine the genetics of the KPC-producing Klebsiella pneumoniae dominant clones
- Recognize genetic features of plasmids disseminating KPC NDM-1 and OXA-48 encoding genes
- Discuss the different epidemiology of producers spreading out and plasmid-mediated carbapenemase interspecific transmission.
$49.99 
 
 
103
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
Genomics is a powerful tool to explore human and pathogen biology in the context of disease mechanisms. These technologies provide a comprehensive analysis of host and/or pathogen genomes. The session will highlight discoveries in human pathogenesis using a variety of genomic approaches. The session will present genome wide association studies pathogen genotyping microbiome studies and whole genome transcriptional analyses to address disease mechanisms. Upon completion of this Symposium Session the participant should be able to:
- Compare the different type of genomic approaches that can be used to study host-pathogen interactions
- Describe how genomic approaches can be used to inform disease models in infectious diseases
- Critically evaluate host and pathogen genomic data
- Recognize pathogen genetic diversity and how this diversity mediates virulence
- Describe how mutations in the host genome can influence patient responses to infection and mediate infection outcomes.
$49.99 
 
 
102
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
Multidrug-resistant bacteria have greatly influenced the development of new antibacterial agents. Pharmacometric approaches and the use of surrogate markers as primary endpoints are being carefully considered and applied as means to improve the evaluation of new antibacterial agents during drug development programs. This symposium will review the recent evidence regarding organism-specific clinical trials of antibacterial agents and the development of endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. In addition representatives from regulatory agencies will provide a prospective on risk: benefit decisions and applications of pharmacometrics for antibacterial drug development programs. Upon completion of this Symposium Session the participant should be able to:
- Describe the use of pharmacometric solutions for antibiotic development programs
- Evaluate the current recommendations on surrogate markers as primary outcome measures in clinical trials
- Appraise the risk-benefit decisions used in antibacterial drug development programs
- Discuss the applications of pharmacometrics by regulatory agencies of antibacterial agents.
$49.99 
 
 
101
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 4
 
The session outlined is designed to provide a high-quality evidence-based educational opportunity to advance the competence and understanding of attending physicians trainees and professionals. Through the review and discussion of interesting and relevant cases important information concerning practice performance and methodology is disseminated throughout the field.Cases and multiple choice questions will be presented to the audience for their response; then the answers and the topics will be discussed. Upon completion of this Interactive Symposium Session the participant should be able to:
- Cite some of the latest significant literature of travelers medicine parasitology and tropical medicine
- Examine the epidemiology of travelers illnesses and will understand issues in management and prevention of these illnesses.
$49.99 
 
 
100
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 1
 
This lively interactive case-based session is designed to address controversies and challenges relevant to the management of patients with HIV infection. Presenters will provide challenging cases around patient management including utilizing infection in HIV/HCV coinfection for discussion of clinically-relevant scenarios. Upon completion of this Interactive Symposium the participant should be able to:
- Discuss initiation of antiretroviral therapy
- Discuss the management of patients on antiretroviral therapy
- Describe the management of patients with HIV/HCV coinfection.
$49.99 
 
 
099
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
ID Quiz
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 3
 
Participate in the ultimate test of infectious diseases knowledge. Which experts are truly experts? Attendees will improve their general knowledge about infectious diseases microbiology and public health especially in relation to recent developments and emerging infections. Upon completion of the ID Quiz the participant should be able to:
- Discuss topics regarding infectious diseases microbiology virology and public health
- Examine recent and new developments in infectious diseases.
$49.99 
 
 
098
Date:
Wednesday, Sep. 11, 2013
 
Time:
1:30 pm –  2:30 pm
 
Track:
Cubist ICAAC Award Lecture
 
Recording Type:
Live Stream
 
Room:
Mile High Ballroom 3
 
$49.99 
 
 
067
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
505
 
Upon the completion of this Slide Session the participant should be able to:
- Assess the epidemiology of healthcare workers hand hygiene
- Practices and evaluate recent issues on successful precaution
- Identify new topics in the hand hygiene research agenda
- Review last research innovations in hand hygiene precaution.
$49.99 
 
 
066
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
207
 
Upon the completion of this Slide Session the participant should be able to:
- Describe role of host immune factors in pathogenesis of C. difficile
- Describe C. difficile virulence factors
- Differentiate impact of antimicrobial agents in producing disease.
$49.99 
 
 
064
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
501
 
In this symposium there will be principles described around the fungal biome at certain host sites and its potential relationship to disease. In this age of powerful tools to understand fungal biology there will be discussion of proteomics and how it impacts the biology and its understanding of molds. We have now performed genomic studies for over a decade on pathogenic fungi so what has it told us and where are we going. Finally how can we use fungal metabolites to help in diagnosis of these difficult-to-treat infections. Upon completion of this Symposium Session the participant should be able to:
- Discuss the principles around the mycobiome
- Examine and review into genomics/proteomic in pathogenic fungi and the principles and potential around them
- Discuss the clinical disease that occurred.
$49.99 
 
 
063
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
Infections of the genitourinary tract are common and the field is challenged by antimicrobial drug resistance. There is a significant need to avoid overtreatment and inappropriate antimicrobial use. This session reviews important concepts in genitourinary tract infections. New information will be presented regarding asymptomatic bacteriuria complications of prostate biopsy/prostatitis and prevention of infection. Upon completion of this Symposium Session the participant should be able to:
- Discuss the importance of identifying asymptomatic bacteriuria
- Recommend strategies for prevention of infections
- Examine the complications of prostate biopsy and multidrug-resistant pathogens
- Recognize the patients who need to be treated for genitourinary tract infection.
$49.99 
 
 
062
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
113
 
Despite the tremendous success of antiretroviral therapy HIV-infected patients remain at high risk for a number of co-morbidities including cardiovascular diseases and cancers. Multiple studies have suggested a role for persistent immune activation and inflammation in the pathogenesis of these co-morbidities. The relevance of the different biomarkers of immune activation inflammation and senescence needs to be discussed as well as strategies that might modulate the levels of these biomarkers. Upon completion of this Symposium Session the participant should be able to:
- Discuss the relevant biomarkers for assessing persistent immune activation inflammation and senescence in patients with HIV infection
- Discuss the relevance of each of these biomarkers with regards to HIV pathogenesis
- Review current and future strategies that might modulate these different biomarkers and impact on patients outcome.
$49.99 
 
 
061
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
503
 
The investigators in this session employ animal models to simulate common pre-natal infections Listeria Salmonella uropathogenic E. coli and toxoplasmosis and to explore the immunologic consequences that determine outcome of pregnancy. Learners interested in understanding how pre-natal infections trigger pregnancy loss and prematurity will want to attend this symposium. Upon completion of this Symposium Session the participant should be able to:
- Discuss the differences among animal models of Listeria Salmonella uropathogenic E. coli and toxoplasmosis
- Identify common mechanisms mediating the consequences of pre-natal infection
- Discuss the functions of Th17 cells and regulatory T-cells.
$49.99 
 
 
060
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
203
 
The quinolone antibiotic class has been one of our most successful weapons in our ongoing battle with bacterial pathogens. These drugs have validated bacterial topoisomerases as important antibacterial targets. In this session we will review the interactions of quinolones with their bacterial targets and explore new chemical compounds that also interact with these DNA replication proteins. It is hoped that new topoisomerase inhibitors can be developed as effective antibacterial agents in the near future. Upon completion of this Symposium Session the participant should be able to:
- Identify how topoisomerase inhibitors kill bacteria
- Gain insights how topoisomerase inhibitors interact with their bacterial targets
- Discuss several new compound classes with the potential for further drug development.
$49.99 
 
 
059
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
405
 
Antibiotic resistance among gram-negatives is evolving at an ever-increasing rate. Attendees at this symposium will receive current information on the polymyxins as compounds for treatment of multidrug-resistant gram-negative infections. Issues related to pharmacokinetic and pharmacodynamic parameters will be addressed. In vitro susceptibility testing challenges and approaches to interpreting testing results will also be discussed. In addition animal models as tools for better understanding the activities of these antimicrobials will be evaluated. Finally clinical outcome assessments among patients receiving these antimicrobials for treatment of infections caused by multidrug-resistant organisms will be reviewed. Upon completion of this Symposium Session the participant should be able to:
- Develop an approach to educate the end users (clinicians pharmacists and clinical microbiologists) on the impact of PK/PD parameters on the clinical use of the polymyxins
- Examine the various animal models which have been used for evaluating pharmacodynamic parameters for the polymyxins and relevant findings
- Recognize various issues and challenges related to the accurate performance of in vitro susceptibility testing of gram-negative pathogens with the polymyxins
- Explain the rationale for current and proposed in vitro testing interpretive criteria for the polymyxins
- Discuss clinical outcomes data among patients receiving polymyxin class compounds for treatment of infections caused by multidrug-resistant gram-negative pathogens.
$49.99 
 
 
058
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
301
 
This symposium will provide an update on the various methods for diagnosis and performance of susceptibility testing for Mycobacterium tuberculosis. Emphasis will be placed on new molecular platforms that are available or in development for detection of Mycobacterium tuberculosis in clinical samples. There will be a lecture on the performance of interferon gamma release assays with suggestions for their appropriate use. Two presentations will be dedicated to the discussion of challenges and breakthroughs in phenotypic and genotypic susceptibility testing of Mycobacterium tuberculosis.Upon completion of this Symposium Session the participant should be able to:
- Discuss current and emerging platforms for the detection of Mycobacterium tuberculosis in clinical specimens
- Examine the advantages and disadvantages of interferon-gamma release assays
- Discuss the challenges of currently available phenotypic and genotypic susceptibility testing for Mycobacterium tuberculosis.
$49.99 
 
 
057
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
401
 
This session will provide an overview on the latest developments regarding C. difficile. The first two lectures will highlight the differences in antimicrobial resistance and molecular epidemiology of C. difficile in North America and Europe. This will be followed by a description of the evolutionary dynamics of hipervirulent C. difficile lineages from different parts of the world and the possibility of using vaccines to combat infection due to this organism. The session is important for all physicians and laboratory personal that are involved in health care aspects of patients infected with C. difficile. Upon completion of this Symposium Session the participant should be able to:
- Recognize the differences in antimicrobial resistance and molecular epidemiology of infection due to C. difficile from North American and Europe
- Describe the evolutionary dynamics of hipervirulent and resistant C. difficile lineages from diverse geographic locations
- Examine the role of proteomics as a tool for C. difficile diagnosis
- Examine the possibilities of using vaccines to combat infection due to C. difficile.
$49.99 
 
 
056
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
112
 
The session aims to provide an overview about the overall knowledge in relation with the resistome meaning the resistance genes as a whole. After an introduction aiming to define what is a resistome and which are the tools to investigate it two lectures will present in detail the current data on the animal and on the environmental resistomes respectively. In addition there will be a focus on the characteristics of plasmids bearing resistance genes and their potential role in dissemination the resistance traits from ecological sites to other ones. Upon completion of this Symposium Session the participant should be able to:
- Discuss what is defining a resistome and what can we expect from its characterization
- Analyze the relationships between human animal and environmental resistance sources
- Discuss updates about the current knowledge on resistance traits in animals
- Examine what can provide fundamental investigations to the clinical microbiology.
$49.99 
 
 
055
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
205
 
Since the discovery of sulfonamides the goal of anti-infective therapy has been to kill the pathogen. However recent science indicates that the host response to the pathogen profoundly influences the clinical course and outcome of infections. Killing the pathogen drives resistance and may not be necessary to treat infections. This symposium will review cutting edge approaches to find new ways to treat infections modulate host response to the pathogen and find new ways to screen for lead anti-infective compounds. Upon completion of this Symposium Session the participant should be able to:
- Examine the definitions of and data regarding static vs. cidal anti-infective strategies
- Discuss the potential for host modulation to alter the course of infection without attacking pathogens
- Describe cutting edge approaches to identify new therapies for infections.
$49.99 
 
 
054
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
Antimicrobial resistance is an urgent public health problem. New ways to prevent the emergence of drug resistance and treat it when present are required. This symposium will address the use of combination antimicrobial chemotherapy for the prevention and management of drug resistance for a range of microbial pathogens. Upon completion of this Symposium Session the participant should be able to:
- Examine the PK/PD principles for treating pneumonia
- Identify the role of measuring drug concentrations within the lung
- Discuss the use of preclinical models of pneumonia for predicting the clinical response to antimicrobial agents.
$49.99 
 
 
053
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 4
 
This interactive symposium will address current challenges in transplantation. This will include preventive strategies related to donor selection in solid organ transplantation and the use of live virus vaccines following transplantation. Difficult to treat viral infections will be considered. Guidelines for safe living after transplantation will be reviewed. Upon completion of this Interactive Symposium Session the participant should be able to:
- Recognize the impact of donor selection on the outcome of solid organ transplant recipients
- Discuss how to recognize and manage adenovirus infections in stem cell transplant recipients
- Evaluate prophylactic measures for transplant recipients including vaccination and strategies for safe living.
$49.99 
 
 
052
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 1
 
Hospital-acquired influenza is associated with significant morbidity and mortality in hospitalized patients. This interactive session provides a debate on nosocomial influenza its transmission routes and effective prevention and control measures. Upon completion of this Interactive Symposium Session the participant should be able to:
- Identify the most effective measures for the prevention and control of nosocomial influenza
- Discuss controversies arising from transmission models
- Describe the components of successful prevention campaigns.
$49.99 
 
 
051a
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
505
 
Healthcare-associated infection surveillance methodology is rapidly evolving given changes in the electronic health record and increased interest in public reporting of healthcare-associated infection (HAI) rates. Traditional surveillance methodology has relied on clinical judgment as a key component of HAI definitions but recent data suggests that issues of inter-rater reliability may make interpretation difficult when comparing rates among institutions and that the use of simple objective and potentially automatable surveillance definitions may be more effective at determining the rank of facilities according to their true underlying infection rates. The speakers will present the rationale and data supporting two new surveillance definitions for central line associated bloodstream infections (CLABSI) and adverse events associated with mechanical ventilation. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Review the advantages and disadvantages of simple objective HAI surveillance definitions
- Identify a proposed novel CLABSI surveillance definition
- Examine a proposed novel surveillance definition for ventilator-associated adverse events.
$49.99 
 
 
051
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
203
 
This meet-the-expert session will focus on issues related to donor derived infections after solid organ transplantation. Hallmarks of donor derived infections will be reviewed. The importance of early recognition with communication of potential infections to health care providers who are caring for the other recipients of a common donor will be discussed. Additionally global reporting systems for donor derived infections will be discussed; the U.S. and French reporting systems will be compared and contrasted. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Recognize key features of post transplant infections that are associated with donor derivation
- Recognize the importance of reporting these infections and how early recognition can impact post transplant outcomes
- Discuss the role of centralized reporting systems for donor derived infections and how the impact of these systems on transplant outcomes.
$49.99 
 
 
050
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
The session outlined is designed to provide a high-quality evidence-based educational opportunity to advance the competence and understanding of attending physicians trainees and professionals. Through the review and discussion of high caliber publications important information concerning practice performance and methodology is disseminated throughout the field. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Cite recent examples of advances in travel and tropical medicine which can be incorporated into their practice and research.
$49.99 
 
 
049
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
113
 
Fusariosis and scedosporiosis are among the more frequent emerging invasive fungal infections. In both diseases treatment outcome depends on early targeted treatment. Experts and audience will discuss the measures to accomplish this goal. Steering targeted treatment prognosis is driven by timing of imaging studies to individualized dosing regimens. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the appropriate treatment in fusariosis and scedosporiosis
- Perform complete diagnostic work ups in these emerging fungal infections
- Measure treatment success
- Discuss how to avoid/recognize treatment failure early.
$49.99 
 
 
048
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
This session will provide an overview on the challenges of healthcare-associated infections in countries with limited resources. It will address specifically the burden of endemic healthcare-associated infections in these countries and highlight possible preventive and surveillance strategies to be implemented in these settings.Upon completion of this Meet-the-Experts Session the participant should be able to:
- Measure the importance of infection prevention in countries with limited resources
- Discuss possible surveillance strategies to be implemented in countries with limited resources
- Identify the most frequent healthcare-associated infections in countries with limited resources
- Discuss the barriers to infection control in countries with limited resources.
$49.99 
 
 
047
Speaker:
 
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
205
 
The Centers for Disease Control and Prevention and the State of New York have published guidelines for evaluation of health-care providers who may have occupational exposure to potential blood-borne pathogens. These guidelines provide for the assessment of the liklihood of infection by the pathogen the provision of post exposure prophylaxis (PEP) to prevent HIV or Hepatitis B transmission and recommendations for follow-up evaluations. However questions remain on the validity of the guidance such as the timing of initiatio of PEP who should be offered PEP best drugs and duration of therapy. Experts will provide scientific rationale for PEP and review the new recommendations. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Review scientific rationale for effectiveness of PEP
- Discuss the challenges of providing PEP in urgent situations
- Examine new therapeutic recommendations
- Discuss the timing dynamics from time of exposure to potential infection based on animal models.
$49.99 
 
 
046
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
501
 
Two experts in stem cell transplantation and solid organ transplant will discuss diagnosis and treatment of common infections in these immunocompromised populations with special emphasis on viral fungal and respiratory pathogens. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the risks and timing of bacterial viral and fungal infections in stem cell and solid organ transplantation in children
- Identify viral and fungal infections and describe their treatment in the pediatric stem cell population
- Identify viral bacterial and fungal infections and describe their treatment in pediatric solid organ transplant patients.
$49.99 
 
 
 
1 - 100 of 124
Order By 
Show 
Last Page
Page 
Next Page
 
ICAACOnline.com © 2015 Digitell, Inc.         Home         Sign In         Cart         Contact Us